Honda’s 2025 U.S. Sales Hit Post-2021 High with 0.5% Growth; China Plant Halts Extended Two Weeks
Honda’s 2025 U.S. sales rose 0.5% year-on-year to a post-2021 high as record light-truck and electrified model deliveries offset a microchip shortage. The automaker has extended production halts at three China plants by two weeks due to ongoing semiconductor supply constraints.
1. U.S. Sales Reach Post-2021 High Despite Chip Shortage
Honda Motor Co. reported U.S. retail deliveries for calendar 2025 of approximately 392,000 vehicles, a 0.5% year-over-year increase and the strongest annual tally since 2021. The gain was driven by all-time record light-truck sales of roughly 275,000 units, up 1.2%, and a 60% surge in electrified vehicle deliveries to about 45,000 units. Sedan volumes held steady at 117,000 units even as microchip constraints trimmed production by an estimated 5,000 units during the fourth quarter. Strong demand for the CR-V, Passport and Pilot SUVs offset supply disruptions, keeping dealer inventories at an average 30 days’ supply versus the industry norm of 45 days. Management reiterated its target of doubling electrified sales by 2027 and forecasts 2026 U.S. volumes to grow by 3–5%, contingent on chip availability improving in the second half of the year.
2. China Production Halt Extended Over Semiconductor Shortage
Honda extended the suspension of manufacturing operations at its three Chinese joint-venture plants until February 28, adding two weeks to an earlier stoppage. The affected facilities—Dongfeng Honda’s Wuhan plant and GAC Honda’s Guangzhou and Zengcheng plants—account for 420,000 units of annual capacity, or roughly 35% of Honda’s China output. The decision follows persistent shortages of critical microcontrollers, which have already trimmed production by an estimated 8,000 vehicles this quarter and delayed deliveries of the Civic and CR-V models by up to six weeks. Honda said it is working with its semiconductor suppliers to secure incremental volumes and mitigate further disruption, but cautioned that any additional delays could impact full-year targets for China sales growth of 10% to 12% in 2026.